-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓Börse SIX Swiss Exchange ZürichCHFISIN CH0013841017-
LonzaBörse SIX Swiss Exchange ZürichISIN CH0013841017 WKN: 928619CHFSymbol LONN
-
LONZA GROUP AG COMMON STOCK CHF 1Börse SIX Swiss Exchange ZürichISIN CH0013841017 WKN: 928619Symbol LONN
-
LONZA GROUP AG-REGBörse Börse DüsseldorfEURSymbol LO3
-
LONZA GROUP AG-REGBörse Quotrix System der Börse DüsseldorfEURSymbol LO3
-
LONZA GROUP AG-REGBörse Börse StuttgartEURSymbol LO3
-
LONZA GROUP AG-REGBörse Börse HamburgEURSymbol LO3
-
LONZA GROUP AG-REGBörse Börse FrankfurtEURSymbol LO3
-
LONZA GROUP AG-REGBörse Gettex System der Börse MünchenEURSymbol LO3
-
LONZA GROUP AG-REGBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol LO3
-
LONZA GROUP AG-REGBörse Börse BerlinEURSymbol LO3
-
LONZA GROUP AG-REGBörse Börse MünchenEURSymbol LO3
-
LonzaBörse Amerikanscher Freiverkehr OTC oder "Pink Sheets"USDSymbol LONN.SW
-
USD
-
CHF
-
CHF
-
USD
-
ISIN CH0013841017
WKN 928619
Symbol LONN
Währung
CHF
Börse
SIX Swiss Exchange Zürich Zeitzone: Europe/London
Marktkapitalisierung
45.174.000.000
Mitarbeiter
17.494
Zahlte zuletzt am 10.05.2021 eine Dividende von 3 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Aktionärsstruktur der Lonza
Entdecke die 6 ETFs in denen Lonza am höchsten gewichtet ist Insgesamt in 58 ETFs enthalten
Dir gefallen die Informationen zu Lonza?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Lonza?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Lonza?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Lonza?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
29 News & Informationen zur Lonza Aktie
Cell Line Development Market|Expected Growth by USD 4.39 Billion at a CAGR of 13.17%|17000+ Technavio Reports
/PRNewswire/ — The cell line development market has the potential to grow by USD 4.39 billion during 2021-2025, and the market's growth momentum will…
The Flow Chemistry Market size would exceed USD 2.77 billion by 2027, says Global Market Insights Inc.
The growth of the flow chemistry market is supported by the growing pharmaceutical sector, surging demand for petrochemicals, mounting need for…
Global Nutricosmetics Market Report 2021-2027 – Asia & Europe at the Forefront of Growth
/PRNewswire/ — The
Global Nutricosmetics Market Report 2021-2027 – Asia & Europe At The Forefront Of Growth
DUBLIN, Aug. 24, 2021 /PRNewswire/ — The
Global Antimicrobial Additives Market to Reach $5.2 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Global $3.7 Billion Empty Capsules Markets to 2026 – Growing Adoption of Capsule Formulations & Advancements in Capsule Delivery Technologies
DUBLIN, Aug. 9, 2021 /PRNewswire/ — The 'Empty Capsules Market by Type (Gelatin (Porcine, Bovine), Non gelatin (HPMC, Pullulan)), Functionality (…
Global Drug Delivery Systems (DDS) Markets 2021-2027 – Increasing R&D Expenditures Of Innovator Companies And The Trend Of Patent Portfolio Expansion
DUBLIN, July 29, 2021 /PRNewswire/ — The
Cosmetic Ingredients Market growth in Commodity Chemicals Industry | Emerging Trends, Company Risk, and Key Executives | Technavio
NEW YORK, July 26, 2021 /PRNewswire/ — Technavio has been monitoring the cosmetic ingredients market and it is poised to grow by USD 3.98 billion…
Lonza Group AG (LZAGY) CEO Pierre-Alain Ruffieux on Q2 2021 Results – Earnings Call Transcript
Lonza Group AG (OTCPK:LZAGY) Q2 2021 Earnings Conference Call July 23, 2021, 08:00 ET Company Participants Pierre-Alain Ruffieux – CEO Rodolfo Savitzky – CFO Conference Call Participants…
Lonza Group Ltd 2021 Q2 – Results – Earnings Call Presentation (OTCMKTS:LZAGY)
The following slide deck was published by Lonza Group Ltd in conjunction with their 2021 Q2 earnings call.
EQS-Adhoc : Lonza Reports Strong Momentum in H1 2021, with 14.7% CER Sales Growth and 33.3% CORE EBITDA Margin
EQS Group-Ad-hoc: Lonza Group AG / Key word: Half Year Results
Lonza Reports Strong Momentum in H1 2021, with 14.7% CER Sales Growth and 33.3% CORE EBITDA Margin
23-Jul-2021 / 07:01 CET/CEST… | July 23, 2021
Cell Culture Media And Reagents Market Growth Analysis In Pharmaceuticals Industry | Discover Company Insights In Technavio
NEW YORK, July 22, 2021 /PRNewswire/ — The cell culture media and reagents market is set to grow by USD 2.26 billion, progressing at a CAGR of about 7% during
Cell Culture Media And Reagents Market Growth Analysis In Pharmaceuticals Industry | Discover Company Insights In Technavio
NEW YORK, July 22, 2021 /PRNewswire/ — The cell culture media and reagents market is set to grow by USD 2.26 billion, progressing at a CAGR of about 7% during
Cell Culture Media And Reagents Market Growth Analysis In Pharmaceuticals Industry | Discover Company Insights In Technavio
NEW YORK, July 22, 2021 /PRNewswire/ — The cell culture media and reagents market is set to grow by USD 2.26 billion, progressing at a CAGR of about 7% during
Cell Culture Media And Reagents Market Growth Analysis In Pharmaceuticals Industry | Discover Company Insights In Technavio
NEW YORK, July 22, 2021 /PRNewswire/ — The cell culture media and reagents market is set to grow by USD 2.26 billion, progressing at a CAGR of about 7% during
Global Wood Preservative Chemicals Market 2021-2027 – Rising Concerns Over Toxicity Push Global Demand For Eco-Friendly Wood Preservative Chemicals
DUBLIN, July 20, 2021 /PRNewswire/ — The “Wood Preservative Chemicals – Global Market Trajectory & Analytics” report has been added to
EQS-Adhoc : Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply
EQS Group-Ad-hoc: Lonza Group AG / Key word: Agreement/Development of Sales
Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply… | July 16, 2021
Global Pharmaceutical Contract Manufacturing Market 2021-2027 – Increasing Significance of Biologic Drugs Fuels Innovations Supports Demand
/PRNewswire/ — The
Global Pharmaceutical Contract Manufacturing Market 2021-2027 – Increasing Significance Of Biologic Drugs Fuels Innovations Supports Demand
DUBLIN, July 15, 2021 /PRNewswire/ — The “Pharmaceutical Contract Manufacturing – Global Market Trajectory & Analytics” report has been added to
Global Pharmaceutical Contract Manufacturing Market 2021-2027 – Increasing Significance of Biologic Drugs Fuels Innovations Supports Demand
DUBLIN, July 15, 2021 /PRNewswire/ — The 'Pharmaceutical Contract Manufacturing – Global Market Trajectory & Analytics' report has been added to …
Clinical Nutrition Market In The Personal Products Industry To Grow By $ 22.20 Bn Through 2025 |Technavio
NEW YORK, June 30, 2021 /PRNewswire/ —
Technavio offers an up-to-date analysis regarding the current global market scenario and the overall market
Global Pharmaceutical Contract Manufacturing Market To Reach $130.2 Billion By 2026
SAN FRANCISCO, June 29, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today
Global Pharmaceutical Contract Manufacturing Market to Reach $130.2 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Lonza : Publishes Restated Financials for 2020
EQS Group-Ad-hoc: Lonza Group AG / Key word: Annual Results/Half Year Results
Lonza Publishes Restated Financials for 2020
29-Jun-2021 / 07:01 CET/CEST
Release of an ad hoc announcement pursuant… | June 29, 2021
Lonza Group Ag (LZAGY) Upgraded to Buy: What Does It Mean for the Stock?
Lonza Group Ag (LZAGY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Niacin and Niacinamide Market Future Developments, Top Companies, Regional Analysis – North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
In its newly compiled report, Future Market Insights (FMI) states that the global niacin and niacinamide market will showcase a steady rise over the forecast
Global Clinical Nutrition Market to 2025 by Route of Administration, Nutrition Type, Application, End User, & Substrates
Dublin, Jan. 14, 2021 (GLOBE NEWSWIRE) — The “Global Clinical Nutrition Market, By Route of Administration (Oral, Intravenous), By Nutrition Type …
Lonza plant in Switzerland starts making ingredients for Moderna COVID shot
Contract drugmaker Lonza said on Monday it has begun manufacturing ingredients for Moderna Inc's COVID-19 vaccine from the first of three new Swiss production lines and expects the initial batch… | January 11, 2021
Covid-19 Vaccines Are in High Demand, but Thousands More Workers Are Needed to Make Them
Contract-manufacturing companies working with Pfizer, Moderna and AstraZeneca to accelerate the global availability of coronavirus shots are struggling with a shortage of their own—the staff to meet the production push.